Xconomy

FEBRUARY 26, 2020

About three years ago fledgling San Diego-based startup PvP Biologics announced a $35 million deal with Takeda Pharmaceutical that gave the Japan pharma giant rights to acquire the company down the line. That day is here.

San Diego 72

San Diego Study Development Develop 72

Xconomy

OCTOBER 30, 2016

Plug and Play San Diego, established in 2013 as a satellite of the Sunnyvale, CA-based incubator, has funneled 15 local startups through the Silicon Valley program after providing some coaching and other services in San Diego.

San Diego 40

San Diego Incubator Avalon Mentor 40

Xconomy

JULY 19, 2016

Synthorx, the San Diego synthetic biology startup that expanded the number of DNA base pairs with two synthetic nucleotides, said today it has raised $10 million in a Series B financing round led by RA Capital Management, the Boston life sciences hedge fund. Existing investors Avalon Ventures and Correlation Ventures joined in the round.

San Diego 40

San Diego Avalon Research Examples 40

Xconomy

APRIL 30, 2018

After demonstrating in 2016 how its synthetic biology technology could produce new biologic drugs , San Diego’s Synthorx today revealed that its lead drug candidate is an improved version of interleukin-2, an anti-cancer drug of intense commercial interest in the 1980s.

Technology 78

Technology Venture Capital San Diego Avalon 78

Xconomy

NOVEMBER 14, 2018

Synthetic biology company Synthorx is laying plans for an initial public offering to raise money to advance its suite of enhanced cytokine drugs.

San Diego 76

San Diego Product Development Develop 76

Xconomy

MAY 2, 2017

View the Slideshow In the not-too-distant future, a “planetary” computer will be able to create a computational model of your body, with the ability to run simulations of your health and to anticipate chronic disease before you show any symptoms.

San Diego 63

San Diego Technical Review Software Review Networking 63

Xconomy

MARCH 23, 2017

Xconomy is convening life sciences and technology founders, executives, investors, and entrepreneurs for an afternoon of fireside chats and solo talks at Human Impact of Innovation.

San Diego 52

San Diego Entrepreneur Technology Avalon 52

Xconomy

JULY 10, 2016

Larry’s diagnosis was cancer with a big C: “I have stage 4 pancreatic cancer and have been on chemo since June with some ups and downs,” he wrote in mid-March. He found he didn’t enjoy being a traditional VC gatekeeper who said “yes” or “no” to startup pitches, according to his wife, Diane. “He They had a lot of fun.”.

San Diego 40

San Diego Startup Avalon Venture Capital 40

Xconomy

AUGUST 31, 2016

In 2009, Tsien and Kevin Kinsella of Avalon Ventures founded San Diego’s Avelas Biosciences to develop fluorescent proteins that change color in the presence of cancer cells. In the statement released by UC San Diego, chancellor Pradeep Khosla said, every honor Tsien received was “justly deserved, and always received with humility.”.

San Diego 72

San Diego UCSD Avalon Study 72

Xconomy

SEPTEMBER 30, 2016

—Shares of New York-based Intra-Cellular Therapies (NASDAQ: ITCI ) plummeted almost 70 percent after its experimental schizophrenia drug came up short in the second of two Phase 3 trials. Bluebird paid Medigene $15 million up front , and could shell out over $1 billion total if a variety of milestones are hit.

Avalon 40

Avalon Thousand Oaks Study Startup 40